Sanghyuk Seo, PharmD, MS

Ferring Pharmaceuticals, Inc.

Poster(s):

• P2588 - Characteristics and Real-World Outcomes of Patients Treated With Fecal Microbiota, Live-jslm (RBL) for the Prevention of Recurrent Clostridioides difficile Infection (rCDI)
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET